Verici Dx Plc Stock Net Income
| VRCDF Stock | USD 0 0.00 0.00% |
Fundamental analysis of Verici Dx allows traders to better anticipate movements in Verici Dx's stock price by examining its financial health and performance throughout various phases of its business cycle.
Verici |
Verici Dx plc Company Net Income Analysis
Verici Dx's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Verici Dx Net Income | (11.41 M) |
Most of Verici Dx's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Verici Dx plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Verici Dx plc reported net income of (11.41 Million). This is 103.34% lower than that of the Biotechnology sector and 106.59% lower than that of the Health Care industry. The net income for all United States stocks is 102.0% higher than that of the company.
Verici Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verici Dx's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Verici Dx could also be used in its relative valuation, which is a method of valuing Verici Dx by comparing valuation metrics of similar companies.Verici Dx is currently under evaluation in net income category among its peers.
Verici Fundamentals
| EBITDA | (10.76 M) | |||
| Net Income | (11.41 M) | |||
| Total Debt | 156 K | |||
| Cash Flow From Operations | (10.07 M) | |||
| Number Of Employees | 14 | |||
| Total Asset | 14.3 M | |||
| Retained Earnings | (24.47 M) | |||
| Working Capital | 8.23 M | |||
| Net Asset | 14.3 M |
About Verici Dx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Verici Dx plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verici Dx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verici Dx plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Verici Pink Sheet
Verici Dx financial ratios help investors to determine whether Verici Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Verici with respect to the benefits of owning Verici Dx security.